Phenolic Composition and Antioxidant, Anti-Inflammatory, Cytotoxic, and Antimicrobial Activities of Cardoon Blades at Different Growth Stages

Biology (Basel). 2022 May 2;11(5):699. doi: 10.3390/biology11050699.

Abstract

Cardoon (Cynara cardunculus var. altilis) blades were collected at sixteen sampling dates (B1-B16) to study the influence of the phenological growth stage on the phenolic composition and biological properties. Twenty phenolic compounds were identified, among which trans 3,4-O-dicaffeoylquinic acid, 5-O-caffeoylquinic acid, and luteolin-O-hexoside (39.6, 42.6, and 101.0 mg/g extract, respectively) were the main compounds. Immature blades (B3) had a higher content of phenolic compounds (178 mg/g extract) and a greater ability to inhibit the formation of thiobarbituric acid reactive substances (IC50 of 1.61 µg/mL). Samples at more advanced growth stages revealed a greater capacity to inhibit oxidative hemolysis (B8, IC50 of 25 and 47.4 µg/mL for Δt of 60 and 120 min, respectively) and higher cytotoxic (B8-B13, GI50 between 7.1 and 17 µg/mL), anti-inflammatory (B13, IC50 of 10 µg/mL), and antibacterial activities. In turn, the antifungal activity varied depending on the tested fungi. All these results suggest that maturity influences the phenolic composition and bioactive properties of cardoon blades, which reveal great potential for the development of bioactive ingredients for food and pharmaceutical applications, among others.

Keywords: antibacterial/antifungal activity; antioxidant activity; cardoon blades; phenolic compounds; phenological growth stage; sustainable ingredients; tumor cell growth inhibition.

Grants and funding

The authors are grateful to the Foundation for Science and Technology (FCT, Portugal) for financial support of national funds FCT/MCTES to CIMO (UIDB/00690/2020); for the F.M. PhD grant (SFRH/BD/146614/2019); and the contracts of J.P. (CEECIND/01001/2018, Project NutriTech), M.I.D., and L.B. (institutional scientific employment program-contract). The authors are grateful to the European Regional Development Fund (ERDF) through the Regional Operational Program North 2020, within the scope of Project GreenHealth, Norte-01-0145-FEDER-000042, and Science and Technological Development of the Republic of Serbia (451-03-68/2020-14/200007). The GIP-USAL is funded by Junta de Castilla y León (Spain) through the Project SA093P20 and the Strategic Research Program for Units of Excellence (ref. CLU-2018-04).